Mixed data for warfarin competitors
Links shared publicly online about this topic.
- 1,890total visits
Mixed data for warfarin competitors
A once-daily factor Xa inhibitor is in a phase 3 trial in patients with AF, but the fate of a warfarin analog hangs in the balance following a disappointing phase 2/3 study.
View full resource at theheart.org
Tags: Phase 3 Clinical Trial, Anti-Clotting Medication, Anticoagulant, Coumadin
Most Recently Shared on July 17, 2009 at 7:15 pm By:
heartwire: Good and bad news for possible warfarin competitors http://bit.ly/2lUGUQ
Advertisement
